Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia

Reproductive Sciences

Volumn 16, Issue 12, 2009, Pages 1135-1143

  Tan, Chia Yee ^a   Chong, Yap Seng ^a   Loganath, Annamalai ^a   Chan, Yiong Huak ^a   Ravichandran, Jeganathan ^b   Lee, Caroline G ^a,c,d   Chong, Samuel S ^a,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b HOSPITAL SULTANAH AMINAH   (Malaysia)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Haplotype; HLA G; KIR2DL4; Placenta; Preeclampsia.

Indexed keywords

HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4;

ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; RISK FACTOR;

CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; LIGANDS; LOGISTIC MODELS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, KIR2DL4; RISK ASSESSMENT; RISK FACTORS;

EID: 70450199766     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719109342280     Document Type: Article

References (53)

1. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000 ; 95 (1). 24-28.
2. Hnat MD, Sibai BM, Caritis S., et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002 ; 186 (3). 422-426.
3. King A., Allan DS, Bowen M., et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol. 2000 ; 30 (6). 1623-1631.
4. King A., Boocock C., Sharkey AM, et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol. 1996 ; 156 (6). 2068-2076.
5. Blaschitz A., Hutter H., Dohr G. HLA Class I protein expression in the human placenta. Early Pregnancy. 2001 ; 5 (1). 67-69.
6. Ishitani A., Sageshima N., Lee N., et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003 ; 171 (3). 1376-1384.
7. Yelavarthi KK, Fishback JL, Hunt JS Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J Immunol. 1991 ; 146 (8). 2847-2854.
8. Kovats S., Main EK, Librach C., Stubblebine M., Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990 ; 248 (4952). 220-223.
9. McMaster MT, Librach CL, Zhou Y., et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. 1995 ; 154 (8). 3771-3778.
10. Colonna M., Navarro F., Bellon T., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997 ; 186 (11). 1809-1818.
11. Allan DS, Colonna M., Lanier LL, et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med. 1999 ; 189 (7). 1149-1156.
12. Colonna M., Samaridis J., Cella M., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 1998 ; 160 (7). 3096-3100.
13. Rajagopalan S., Long EO A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 1999 ; 189 (7). 1093-1100.
14. Shiroishi M., Tsumoto K., Amano K., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A. 2003 ; 100 (15). 8856-8861.
15. Carreiras M., Montagnani S., Layrisse Z. Preeclampsia: a multi-factorial disease resulting from the interaction of the fetomaternal HLA genotype and HCMV infection. Am J Reprod Immunol. 2002 ; 48 (3). 176-183.
16. Hylenius S., Andersen AM, Melbye M., Hviid TV Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod. 2004 ; 10 (4). 237-246.
17. Moreau P., Contu L., Alba F., et al. HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage. Biol Reprod. 2008 ; 79 (3). 459-467.
18. ́Brien M., McCarthy T., Jenkins D., et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci. 2001 ; 58 (12-13). 1943-1949.
19. Witt CS, Whiteway JM, Warren HS, et al. Alleles of the KIR2DL4 receptor and their lack of association with preeclampsia. Eur J Immunol. 2002 ; 32 (1). 18-29.
20. Tan CY, Ho JF, Chong YS, et al. Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies. Mol Hum Reprod. 2008 ; 14 (5). 317-324.
21. Clayton D. SNPhap: a program for estimating frequencies of large haplotypes of SNPs (version 1.2). http://www.-gene.cimr.cam.ac.uk/clayton/ software/snphap.txt. May 1, 2007.
22. Martin AM, Freitas EM, Witt CS, Christiansen FT The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics. 2000 ; 51 (4-5). 268-280.
23. Wilson MJ, Torkar M., Haude A., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A. 2000 ; 97 (9). 4778-4783.
24. Barten R., Torkar M., Haude A., Trowsdale J., Wilson MJ Divergent and convergent evolution of NK-cell receptors. Trends Immunol. 2001 ; 22 (1). 52-57.
25. Goodridge JP, Witt CS, Christiansen FT, Warren HS KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol. 2003 ; 171 (4). 1768-1774.
26. Valiante NM, Uhrberg M., Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1997 ; 7 (6). 739-751.
27. Ponte M., Cantoni C., Biassoni R., et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: deciduaassociated natural killer cells express LIR-1 and CD94/ NKG2a and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A. 1999 ; 96 (10). 5674-5679.
28. Faure M., Long EO KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol. 2002 ; 168 (12). 6208-6214.
29. Kikuchi-Maki A., Yusa S., Catina TL, Campbell KS KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol. 2003 ; 171 (7). 3415-3425.
30. Rajagopalan S., Fu J., Long EO Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol. 2001 ; 167 (4). 1877-1881.
31. Riteau B., Menier C., Khalil-Daher I., et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol. 2001 ; 13 (2). 193-201.
32. Choi SJ, Park JY, Lee YK, et al. Effects of cytokines on VEGF expression and secretion by human first trimester trophoblast cell line. Am J Reprod Immunol. 2002 ; 48 (2). 70-76.
33. Fujii T., Ishitani A., Geraghty DE A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 1994 ; 153 (12). 5516-5524.
34. Hiby SE, King A., Sharkey A., Loke YW Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens. 1999 ; 53 (1). 1-13.
35. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3ĝ€™ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol. 2003 ; 64 (11). 1005-1010.
36. Hviid TV, Hylenius S., Rorbye C., Nielsen LG HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics. 2003 ; 55 (2). 63-79.
37. Shiroishi M., Kuroki K., Ose T., et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem. 2006 ; 281 (15). 10439-10447.
38. Gomez-Lozano N., de Pablo R., Puente S., Vilches C. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur J Immunol. 2003 ; 33 (3). 639-644.
39. Norman PJ, Carrington CV, Byng M., et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun. 2002 ; 3 (2). 86-95.
40. LeMaoult J., Zafaranloo K., Le Danff C., Carosella ED HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 2005 ; 19 (6). 662-664.
41. Yan WH, Fan LA Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res. 2005 ; 15 (3). 176-182.
42. Boyson JE, Erskine R., Whitman MC, et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci U S A. 2002 ; 99 (25). 16180-16185.
43. Cantoni C., Verdiani S., Falco M., et al. P49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 1998 ; 28 (6). 1980-1990.
44. Gedil MA, Steiner NK, Hurley CK Genomic characterization of KIR2DL4 in families and unrelated individuals reveals extensive diversity in exon and intron sequences including a common frameshift variation occurring in several alleles. Tissue Antigens. 2005 ; 65 (5). 402-418.
45. Rajalingam R., Gardiner CM, Canavez F., Vilches C., Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-caucasian donors. Tissue Antigens. 2001 ; 57 (1). 22-31.
46. Selvakumar A., Steffens U., Dupont B. NK cell receptor gene of the KIR family with two Ig domains but highest homology to KIR receptors with three Ig domains. Tissue Antigens. 1996 ; 48 (4 pt 1). 285-294.
47. Selvakumar A., Steffens U., Palanisamy N., Chaganti RS, Dupont B. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. Tissue Antigens. 1997 ; 49 (6). 564-573. (Pubitemid 27268683)
48. Robinson J., Waller MJ, Stoehr P., Marsh SG IPD-the Immuno Polymorphism Database. Nucleic Acids Res. 2005 ; 33 (database issue): D523 - D526.
49. Marsh SG, Parham P., Dupont B., et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol. 2003 ; 64 (6). 648-654. (Pubitemid 36706060)
50. Li Y., Zhao YH, Zhang WY, Cui MH Correlation between killer cell immunoglobulin-like receptors genes and pre-eclampsia. Zhonghua Fu Chan Ke Za Zhi. 2008 ; 43 (12). 909-912.
51. Witt CS, Martin A., Christiansen FT Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens. 2000 ; 56 (3). 248-257.
52. Trundley A., Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens. 2004 ; 63 (1). 1-12.
53. Hiby SE, Walker JJ, ́Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004 ; 200 (8). 957-965.